查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198092

预装色谱柱市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Prepacked Chromatography Columns Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，预装色谱柱市场预计将以 6.9% 的复合年增长率註册。

COVID-19 大流行对预装色谱柱市场产生了重大影响。 这是由于各种因素造成的，例如疫苗生产对预装层析柱的需求增加、生物製药研发活动增加以及在各种药物开发过程中的应用增加。 此外，市场上的主要参与者也受益于色谱树脂需求的激增。 例如，在 2021 年，Repligen 将产生约 1.9 亿美元与其 COVID-19 计划相关的收入，包括用于后期临床和商业流程的 OPUS 预装层析柱的收入，包括 COVID-19 疫苗工作流程在内的收益。 因此，COVID-19 的爆发对预装色谱柱市场的增长产生了重大影响。

对工艺开发、经济实惠的纯化和预装色谱柱技术进步的需求不断增长，是推动所研究市场增长的关键因素。 在生物製药行业，预装柱广泛应用于工艺开发和生物製造。 预装色谱柱越来越多地被采用，因为它们可以实现一致的生产，同时卸载昂贵且耗时的装填程序和相关的验证协议。

不断增加的技术创新和产品发布也在推动市场增长。 例如，2022 年 9 月，Tosoh Bioscience GmbH 推出了 Octave BIO 多柱色谱 (MCC) 系统。 该系统与 2020 年 4 月推出的 SkillPak BIO 预装柱结合使用。 这种新色谱系统的产品推出增加了对公司 SkillPak 预装柱的需求。 预计这将在预测期内推动市场增长。

因此，增加对药物研究活动的投资和预装色谱柱的技术进步有望在预测期内加速市场增长。 然而，色谱柱的技术限制可能会阻碍市场增长。

预装色谱柱的市场趋势

亲和列增长预期

亲和层析是一种允许根据蛋白质的生物学功能而不是它们各自的物理或化学性质来纯化蛋白质的技术。 亲和层析是一种用于初级捕获和纯化各种蛋白质、核酸、病毒载体、外泌体等的首选技术。 对治疗性蛋白质的需求不断增加，亲和膜色谱在生物製药行业的广泛使用，以及亲和树脂的不断创新正在推动这一领域的增长。 例如，2022年2月，Repligen公司推出了AVIPure AAV亲和树脂，有望在基因治疗製造中有重要应用。 新推出的树脂在 OPUS 预装柱中提供。 此外，生物技术领域的增长补充了对预装层析柱的需求。 例如，根据 Invest India 在 2022 年发布的数据，印度的生物技术行业在 2022 年增长了 14%，超过 801 亿美元。

此外，市场主要参与者的新产品发布和战略活动对所研究市场的增长产生了积极影响。 例如，2021 年 2 月，Repligen 和 Navigo Proteins 推出了一种亲和树脂，该树脂也有现成的、预装的和预认证的 OPUS 柱配置，用于纯化 COVID-19 疫苗。 这大大加强了我们的产品组合。 因此，由于产品发布和技术进步，研究部门预计在预测期内将显着增长。

预计北美将主导市场

由于高研发成本、成熟的实验室以及预装色谱柱的现成可用性等因素，预计北美将主导市场。 根据美国研究与製药製造商协会的数据，2021 年 PhRMA 会员企业的研发投入将创下 1023 亿美元的历史新高。 此外，美国众多製药和生物製药公司的存在也是促进北美研究目标市场增长的重要因素之一。

大量的合作伙伴关係和协作，以及市场参与者集中在美国，也是推动预装色谱柱市场增长的因素。 2020 年 3 月，Astrea Bioseparations 与 Thermo Fisher Scientific 就预装生物分离柱签署了协议。 该非排他性供应协议用于製造包含 Thermo Fisher Scientific 的 CaptureSelect 和 POROS 层析树脂的预装 EvolveD 柱。 该合作伙伴关係有望显着加强公司的产品阵容。 该地区的这种持续发展有望推动北美地区研究市场的增长。

预装色谱柱市场竞争者分析

由于多家公司在全球和区域运营，预装层析柱市场有些分散。 竞争格局包括该行业的大型市场，例如 Danaher Corporation (Cytiva)、Repligen Corporation、Merck KGaA、Thermo Fisher Scientific Inc.、Sartorius AG、Bio-Rad Laboratories Inc、Proxcys BV、YMC Europe GmbH、Tosoh Corporation、Astrea Bioseparations . 包括对少数全球公司股票的分析。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查先决条件和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 对工艺开发和负担得起的精炼的需求增加
    • 预装色谱柱的技术进步
  • 市场製约因素
    • 色谱柱的技术限制
  • 行业吸引力 - 波特五力分析
    • 新进入者的威胁
    • 买家的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按树脂类型
    • 亲和力
    • 离子交换树脂
    • 其他树脂类型
  • 按容量
    • 10毫升或更少
    • 10-1000ml
    • 1000毫升或更多
  • 最终用户
    • 製药/生物工业
    • 学术研究领域
    • 其他最终用户
  • 按地区细分
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Danaher Corporation（Cytiva）
    • Repligen Corporation
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Bio-Rad Laboratories Inc.
    • Proxcys BV
    • YMC Europe GmbH
    • Tosoh Corporation
    • Astrea Bioseparations

第7章 市场机会今后动向

简介目录
Product Code: 93223

The prepacked chromatography columns market is expected to register a CAGR of 6.9% over the forecast period.

The COVID-19 pandemic had a significant impact on the prepacked chromatography columns market. This can be attributed to various factors, such as increasing demand for prepacked chromatography columns for vaccine manufacturing, increasing R&D activities for biopharmaceuticals, and increasing application in different drug development processes. Furthermore, the key players in the market also benefitted from the surge in chromatography resin demand. For instance, in 2021, Repligen generated about USD 190 million in revenue related to COVID-19 programs, which included revenue from OPUS prepacked chromatography columns for late-stage clinical and commercial processes, including COVID-19 vaccine workflows. Thus, the COVID-19 outbreak significantly impacted the growth of the prepacked chromatography column market.

Increasing demand for process development, affordable purification, and technological advancements in prepacked chromatography columns are among the significant factors driving the growth of the studied market. In the biopharmaceutical industry, prepacked columns are widely employed for process development and biomanufacturing. Prepacked chromatography columns are increasingly being adopted as it takes away the burden of costly and time-consuming packing procedures and associated validation protocols, thereby ensuring consistent production.

Also, increasing innovation and product launches are driving the market's growth. For instance, in September 2022, Tosoh Bioscience GmbH launched the Octave BIO Multi-Column Chromatography (MCC) system. This system works with SkillPak BIO prepacked columns launched in April 2020. This product launch of a new chromatography system augments the demand for its SkillPak Prepacked Columns. This is expected to propel the market growth over the forecast period.

Thus, increasing investment in pharmaceutical research activities and technological advancements in prepacked chromatography columns are poised to accelerate market growth over the forecast period. However, the technical limitations of the column are likely to impede market growth.

Prepacked Chromatography Columns Market Trends

Affinity Segment Expected to Witness Growth

Affinity chromatography is the technique that allows the purification of proteins based on biological functions rather than individual physical or chemical properties. Affinity chromatography is the preferred approach for the primary capture and purification of different proteins, nucleic acids, viral vectors, and exosomes. Increasing demand for therapeutic protein, wide usage of affinity membrane chromatography in the biopharmaceutical industry, and increasing innovation in affinity resins are propelling the segment's growth. For instance, in February 2022, Repligen Corporation launched AVIPure AAV affinity resins which are anticipated to have a significant application in gene therapy manufacturing. The newly launched resin is available in OPUS prepacked columns. Moreover, the growing biotechnological sector is supplementing the demand for prepacked chromatography columns. For instance, according to the data published by Invest India in 2022, the Indian biotech sector grew by 14% and crossed USD 80.1 billion in 2022.

Furthermore, new product launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For instance, in February 2021, Repligen and Navigo Proteins launched an affinity resin, also available in off-the-shelf, prepacked, and pre-qualified OPUS Columns configuration, for the purification of COVID-19 vaccines. This significantly strengthened its product portfolio. Thus, due to product launches and technological advancements, the studied segment is expected to grow considerably over the forecast period.

North America Expected to Dominate the Market

North America is expected to dominate the market owing to factors such as high R&D spending, well-established research organizations, and the easy availability of prepacked chromatography columns. According to the Pharmaceutical Research and Manufacturers of America, PhRMA member companies' R&D investments reached a record high of USD 102.3 billion in 2021. In addition, the presence of a high number of pharmaceutical and biopharmaceutical companies in the United States is among the key factors contributing to the growth of the studied market in North America.

A high number of partnerships and collaborations and a high concentration of market players in the United States are some of the factors driving the growth of the prepacked chromatography columns market. In March 2020, Astrea Bioseparations came into agreement with Thermo Fisher Scientific for prepacked bioseparation columns. This non-exclusive supply agreement with Thermo Fisher Scientific to manufacture pre-packed EvolveD columns that will include CaptureSelect and POROS chromatography resins of Thermo Fisher Scientific. This collaboration is anticipated to significantly enhance their product offering. Such continuous developments in the region are anticipated to drive the growth of the studied market in the North America region.

Prepacked Chromatography Columns Market Competitor Analysis

The prepacked chromatography columns market is slightly fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few global companies which hold significant market share in the industry, including Danaher Corporation (Cytiva), Repligen Corporation, Merck KGaA, Thermo Fisher Scientific Inc., Sartorius AG, Bio-Rad Laboratories Inc., Proxcys BV, YMC Europe GmbH, Tosoh Corporation, Astrea Bioseparations, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Process Development and Affordable Purification
    • 4.2.2 Technological Advancements in Prepacked Chromatography Columns
  • 4.3 Market Restraints
    • 4.3.1 Technical Limitations of the Column
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Resin Type
    • 5.1.1 Affinity
    • 5.1.2 Ion Exchange
    • 5.1.3 Other Resin Types
  • 5.2 By Volume Type
    • 5.2.1 Below 10 ml
    • 5.2.2 10-1000 ml
    • 5.2.3 Above 1000 ml
  • 5.3 By End-user
    • 5.3.1 Pharmaceutical and Biopharmaceutical Industry
    • 5.3.2 Academic Research
    • 5.3.3 Other End-users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of the Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of the Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of the South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danaher Corporation (Cytiva)
    • 6.1.2 Repligen Corporation
    • 6.1.3 Merck KGaA
    • 6.1.4 Thermo Fisher Scientific Inc.
    • 6.1.5 Sartorius AG
    • 6.1.6 Bio-Rad Laboratories Inc.
    • 6.1.7 Proxcys BV
    • 6.1.8 YMC Europe GmbH
    • 6.1.9 Tosoh Corporation
    • 6.1.10 Astrea Bioseparations

7 MARKET OPPORTUNITIES AND FUTURE TRENDS